Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria

International Journal of Antimicrobial Agents

Volumn 41, Issue 4, 2013, Pages 383-387

  Kristo, Ioulia ^a   Pitiriga, Vassiliki ^b   Poulou, Aggeliki ^b,c   Zarkotou, Olympia ^d   Kimouli, Maria ^e   Pournaras, Spyros ^a   Tsakris, Athanassios ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c General District Hospital of Serres   (Greece)

^d TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^e Saint Panteleimon Hospital   (Greece)

Author keywords

CLSI breakpoints; Extended spectrum lactamase; Extended spectrum cephalosporins

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLACTX M 15 GENE; BLACTX M 3 GENE; BLASHV 5 GENE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GREECE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; GREECE; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84875304034     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.12.003     Document Type: Article

References (15)

1. J.D. Pitout, and K.B. Laupland Extended-spectrum β-lactamase- producing Enterobacteriaceae: an emerging public-health concern Lancet Infect Dis 8 2008 159 166
2. M. Melzer, and I. Petersen Mortality following bacteraemic infection caused by extended spectrum β-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli J Infect 55 2007 254 259
3. D.L. Paterson, W.C. Ko, A. Von Gottberg, J.M. Casellas, L. Mulazimoglu, and K.P. Klugman Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory J Clin Microbiol 39 2001 2206 2212
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
5. F.J. Robberts, P.C. Kohner, and R. Patel Unreliable extended-spectrum β-lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical isolates J Clin Microbiol 47 2009 358 361
6. D. Andes, and W.A. Craig Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations Clin Microbiol Infect 11 Suppl. 6 2005 10 17
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010.
8. P.L. Ho, K.H. Chow, W.U. Lo, K.K. To, and V.C. Cheng Effect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong Int J Antimicrob Agents 37 2011 270 271
9. C.C. Huang, Y.S. Chen, H.S. Toh, Y.L. Lee, Y.M. Liu, and C.M. Ho Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010 Int J Antimicrob Agents 40 Suppl. 1 2012 S4 S10
10. P. Wang, F. Hu, Z. Xiong, X. Ye, D. Zhu, and Y.F. Wang Susceptibility of extended-spectrum β-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints J Clin Microbiol 49 2011 3127 3131
11. D.M. Livermore, J.M. Andrews, P.M. Hawkey, P.L. Ho, Y. Keness, and Y. Doi Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? J Antimicrob Chemother 67 2012 1569 1577
12. A. Agodi, E. Voulgari, M. Barchitta, L. Politi, V. Koumaki, and N. Spanakis Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy J Clin Microbiol 49 2011 3986 3989
13. M. Perilli, E. Dell'Amico, B. Segatore, M.R. de Massis, C. Bianchi, and F. Luzzaro Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey J Clin Microbiol 40 2002 611 614
14. R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, and F. Baquero Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe Clin Microbiol Infect 14 Suppl. 1 2008 144 153
15. K.R. de Oliveira, A.L. de Freitas, D.M. Willers, A.L. Barth, and A.P. Zavascki High frequency of β-lactam susceptibility in CTX-M-type extended-spectrum-β-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations J Antimicrob Chemother 65 2010 2481 2483